医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Analysis Group to Present Health Economics, Treatment Pattern, and Outcomes Research Based on Big Electronic Medical Record Data in China at ISPOR 6th Asia-Pacific Conference

2014年09月02日 PM10:00
このエントリーをはてなブックマークに追加


 

BEIJING

Members of Analysis Group’s Health Care Consulting Services practice will exhibit a poster, moderate a podium session, and instruct a short course at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 6th Asia-Pacific Conference in Beijing, China, from September 6–9, 2014.

A team from Analysis Group, led by Managing Principal Eric Qiong Wu, Ph.D., and Vice President Jipan Xie, M.D., Ph.D., will present the poster “Treatments and Monitoring of Venous Thromboembolism (VTE) among Hospitalized Patients in China,” which is based on a study undertaken in collaboration with researchers at Peking Union Medical College and Peking University Shenzhen Hospital.

“This is the first study to examine treatment and monitoring of VTE care in China using large and rich electronic medical record (EMR) data,” notes Dr. Wu. “Compared to other data sources in China, EMR data from major medical institutions provide superior accuracy, consistency, and richer clinical and economic information. Its completeness is not limited by insurance coverage of medical services and products, making it a preferred source of scientific data for health care research in China.”

In addition, Dr. Xie will moderate the “Cardiovascular Disease Outcomes Research Studies” podium session and co-instruct the “Introduction to Modeling” short course. Analysis Group’s academic affiliate Professor Gordon Liu, Director of the China Center for Health Economics Research at Peking University, will serve as conference chair.

“We are looking forward to opportunities to share our research using new sources of medical big data and cutting-edge research methods, and to reinforce our position as a leading research group in the field,” said Dr. Wu, who heads up Analysis Group’s Beijing office.

Analysis Group is proud to sponsor the conference and will be a featured exhibitor. Please look for us at Booth #16.

About Analysis Group

One of the largest economic consulting firms based in North America, Analysis Group (www.analysisgroup.com) provides health outcomes research and economic consulting to leading corporations, organizations, and government agencies. The firm’s more than 500 professionals have advanced degrees in such disciplines as health economics and outcomes research, epidemiology, product and market strategy, biostatistics, and economics, and work from offices in Boston, Chicago, Dallas, Denver, Los Angeles, Menlo Park, New York, San Francisco, Washington, D.C., Beijing, and Montreal.

CONTACT

Analysis Group
Eileen Harrington, 617-425-8193
eileen.harrington@analysisgroup.com

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続